Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease.
about
Effect of pioglitazone treatment on behavioral symptoms in autistic childrenCannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvementRegulation of oligodendrocyte progenitor cell maturation by PPARδ: effects on bone morphogenetic proteinsA transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis.Effects of long-term pioglitazone treatment on peripheral and central markers of aging.Chronic immobilisation stress ameliorates clinical score and neuroinflammation in a MOG-induced EAE in Dark Agouti rats: mechanisms implicated.Insulin resistance in Alzheimer's disease.Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanismsLong-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's diseaseThe PPAR-Platelet Connection: Modulators of Inflammation and Potential Cardiovascular Effects.Managing psychiatric disorders with antidiabetic agents: translational research and treatment opportunities.Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes.15-deoxy-Delta12,14-prostaglandin J2 (15d-PGJ2) and ciglitazone modulate Staphylococcus aureus-dependent astrocyte activation primarily through a PPAR-gamma-independent pathway.Thiazolidinediones: novel treatments for cognitive deficits in mood disorders?Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's DiseaseStress-induced neuroinflammation: mechanisms and new pharmacological targets.Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia.Insulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets.Is there a role for the nuclear receptor PPARγ in neuropsychiatric diseases?Therapeutic Potential of PPARγ Activation in Stroke.Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.PPAR-gamma Thiazolidinedione Agonists and Immunotherapy in the Treatment of Brain Tumors.The Atypical Antipsychotic Paliperidone Regulates Endogenous Antioxidant/Anti-Inflammatory Pathways in Rat Models of Acute and Chronic Restraint Stress.Rosiglitazone suppresses glioma cell growth and cell cycle by blocking the transforming growth factor-beta mediated pathway.Distinct modulation of voltage-gated and ligand-gated Ca2+ currents by PPAR-gamma agonists in cultured hippocampal neurons.RETRACTED: Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy.Diabesity and Brain Energy Metabolism: The Case of Alzheimer's Disease.Genetic Deletion of Neuronal PPARγ Enhances the Emotional Response to Acute Stress and Exacerbates Anxiety: An Effect Reversed by Rescue of Amygdala PPARγ Function.The role of Wnt signaling in neuronal dysfunction in Alzheimer's Disease.Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease.PPARs: a new target for neuroprotection.PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial.Essential fatty acid-rich diets protect against striatal oxidative damage induced by quinolinic acid in rats.Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms.Peroxisome proliferator-activated receptor gamma up-regulates the Bcl-2 anti-apoptotic protein in neurons and induces mitochondrial stabilization and protection against oxidative stress and apoptosis.A novel thiazolidinediones ATZD2 rescues memory deficits in a rat model of type 2 diabetes through antioxidant and antiinflammation.Effects of peroxisome proliferator-activated receptor gamma agonists on brain glucose and glutamate transporters after stress in rats.PPARβ/δ and γ in a rat model of Parkinson's disease: possible involvement in PD symptoms.Peroxisome proliferator-activated receptor gamma activation relieves expression of behavioral sensitization to methamphetamine in mice.
P2860
Q21245241-FA678E69-CE88-4781-B059-B8228CC9FC8EQ28394506-5B47798C-A986-4752-8313-81EFD155F3BEQ33595538-A674F78B-70DE-4999-9D58-E4CE696C7CEFQ33769952-F46A57AF-1397-4C1D-882A-BDF11D26971BQ33818388-69523DCA-C17B-456D-92F1-458A1BF9DE73Q34220882-C88B6E33-937D-4D12-B778-7744BADD4553Q34622157-8BA76E03-AF67-45F8-8B65-8D76003EC1E4Q35085272-6674AA7B-55A2-45D1-AE8F-054D3BD7DA77Q36044265-4A7BDE61-69E5-422F-AB4D-F7EFAD427FEBQ36445381-9B77FEA5-6C7E-44C0-83EE-3EF2B58517E6Q36521858-D9CC67A6-1E95-41B0-BA0A-14487014410BQ36684873-1DA52911-60DB-43C4-B864-0A035E1845A7Q36712237-7821FE89-0CB7-4FDD-B322-B7E7F1E4BA3BQ36904879-5BDF3D4B-EBE4-4137-9968-3EA1B5D1E88DQ36992256-9F79F3BA-D1CC-4D7E-B543-0D54BC0D6D11Q37211800-3850C80F-02EA-49F7-8704-6C85A5989605Q37369927-581C789D-59ED-40B1-8018-47F712069F34Q37598239-84CFA529-2D2B-49F3-9608-4740600FB0EFQ37689883-6E25479F-CD65-4BF7-8950-C25B34612DCDQ37783637-3D27C0FA-63DB-4781-A4DC-8EA480A1C46EQ37930425-DFE1612C-3D81-4A5F-B707-8DFF257B109FQ38272127-F73306BA-1DDA-4730-8AA5-B526FAC506A6Q38620031-D8DC6405-159E-4C41-870A-3256FC4A2BF6Q38809746-B5067E84-204E-4B07-A743-71ACB1A4FC20Q39329694-3E8ECB55-7752-429E-8994-E8FF78056696Q41148387-2A4FB216-69B7-45D5-9D85-F99BDA2F4DB4Q41872993-54DBEFF7-64E8-4D4C-83B8-1FE54271DD7EQ41995767-EC5D8601-2902-4178-BEF9-39F6AE60B3C7Q42352612-067E7F78-6883-4F1A-967E-2CB5634D52A1Q42390629-3E148CAD-8C2B-4999-B152-550E9D75AB9AQ42656054-D4090D99-5F9E-4D8E-908B-437E113D705AQ42718625-66810112-FC80-4459-9E2A-59EFC20D1965Q45058991-75E8A4B9-5341-441F-A3EF-57004BBDFBC0Q45293662-58E077A4-6EF7-4449-AA97-85D67F753DB4Q46611073-5D01EF58-50A5-4C66-A59C-5C545F3D7AD9Q46927529-25E7C6A7-C2D4-43BA-ACBA-E18B94347761Q47136653-FF0DC35B-8ADC-4A4B-904A-31E39C27AADBQ48362500-26204184-09E7-4772-99F6-8659C303A2E2Q48403821-78FE63FF-6F08-4B57-85E0-9ED4A9C169BAQ48405117-8A134BC3-DB9F-49D8-B242-ED42CC344473
P2860
Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological disease.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Therapeutic potential of perox ...... ists for neurological disease.
@ast
Therapeutic potential of perox ...... ists for neurological disease.
@en
type
label
Therapeutic potential of perox ...... ists for neurological disease.
@ast
Therapeutic potential of perox ...... ists for neurological disease.
@en
prefLabel
Therapeutic potential of perox ...... ists for neurological disease.
@ast
Therapeutic potential of perox ...... ists for neurological disease.
@en
P1476
Therapeutic potential of perox ...... ists for neurological disease.
@en
P2093
Douglas L Feinstein
P356
10.1089/152091503763816481
P577
2003-01-01T00:00:00Z